|
|
|
| Clinical Efficacy and Safety Analysis of Danhong Injection in Treating Acute Cerebral Infarction |
| CAO Yujing, HUANG Huanhuan, DUAN Danhui, et al |
| The First Affiliated Hospital of Harbin Medical University, Heilongjiang Harbin 150001, China |
|
|
|
|
Abstract Objective: To investigate the clinical efficacy and safety of Danhong injection in the treatment of acute cerebral infarction. Methods: 300 patients with acute cerebral infarction who were hospitalized from January 2015 to October 2017 were randomly divided into two groups. Patients in the traditional group were treated with western medicine combined with Danhong injection. Patients in the two groups were compared Symptoms, overall treatment, coagulation, endothelial function and safety. Results: After treatment, the main symptoms in the combined group were significantly lower than those in the traditional group. The total effective rate was significantly higher than that in the traditional group. After treatment, the levels of PT, APTT, 6-keto-PGF1α and NO were significantly different The levels of Fib, D-dimer, ET-1 and TXB2 were significantly lower than those in the traditional group (P<0.01). The blood parameters, liver function and kidney There is no significant difference between the power indicators (P>0.05). Conclusion: Danhong injection has significant clinical effect and high safety in the treatment of acute cerebral infarction.
|
|
|
|
|
|
[1] 许静,田青.依达拉奉联合丹红注射液治疗急性脑梗死43例疗效观察[J].海南医学,2015,26(21):3199~3201.
[2] 曹良.醒脑静联合丹红注射液治疗急性脑梗死临床疗效观察[J].西南国防医药,2015,25(6):652~654.
[3] 熊维,常飞.脑心通胶囊联合丹红注射液治疗急性脑梗死的临床疗效及其机制探讨[J].华中科技大学学报(医学版),2016,45(1):74~77.
[4] 石进,王科花.对《中药新药治疗中风临床研究技术指导原则》中疗效评估的解读[J].中国新药杂志,2017,26(09):973~975.
[5] 冯琼,涂明义,张武昌,等.急诊rt-PA动脉溶栓联合丹红注射液治疗急性脑梗死的临床研究[J].中国中医急症,2016,25(2):239~241.
[6] 陆伦,杨小芳.丹红注射液治疗急性脑梗死的临床研究[J].四川医学,2014,35(1):64~65. |
|
|
|
2019, Vol. 25 
